Researcher at Navamindradhiraj University Details Research in Dengue Hemorrhagic Fever (The Adjuvant Activity of BCG Cell Wall Cytoskeleton on a Dengue Virus-2 Subunit Vaccine).

Předmět:	DENGUE hemorrhagic fever BCG immunotherapy DENGUE CYTOSKELETON BCG vaccines
Zdroj:	Vaccine Weekly; 9/1/2023, p270-270, 1p
Abstrakt:	Keywords: BCG Vaccines; Bacillus Calmette-Guerin Vaccines; Bacterial Vaccines; Biological Products; Cell Wall; Cellular Structures; Cytoplasmic Structures; Cytoskeleton; Dengue Virus; Flaviviridae; Flavivirus; Health and Medicine; Immunization; Immunization and Public Health; Intracellular Space; Mosquito-Borne Diseases; RNA Viruses; Subunit Vaccines; Tuberculosis Vaccines; Vaccines; Viral; Virology EN BCG Vaccines Bacillus Calmette-Guerin Vaccines Bacterial Vaccines Biological Products Cell Wall Cellular Structures Cytoplasmic Structures Cytoskeleton Dengue Virus Flaviviridae Flavivirus Health and Medicine Immunization Immunization and Public Health Intracellular Space Mosquito-Borne Diseases RNA Viruses Subunit Vaccines Tuberculosis Vaccines Vaccines Viral Virology 270 270 1 08/28/23 20230901 NES 230901 2023 AUG 30 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators discuss new findings in dengue hemorrhagic fever. This vaccine candidate was administered in the presence of BCG cell wall cytoskeleton (BCG-CWS) as an adjuvant. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu